Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1500 | AZD2014 | 0.01 | -0.9946 | 0.02284 |
| HCC1500 | AZD2014 | 0.00316227766017 | -0.9938 | -0.07021 |
| HCC1500 | LY3023414 | 1.0 | -0.9938 | 0.00627 |
| HCC1500 | LY3023414 | 0.0316227766017 | -0.9937 | 0.04399 |
| HCC1500 | AZD2014 | 0.001 | -0.9931 | -0.03111 |
| HCC1500 | LY3023414 | 10.0 | -0.9929 | 0.03592 |
| HCC1500 | AZD2014 | 0.00316227766017 | -0.9926 | -0.05570 |
| HCC1500 | LY3023414 | 0.01 | -0.9903 | -0.02829 |
| HCC1500 | RO-3306 | 10.0 | -0.9896 | -0.04607 |
| HCC1500 | LY3023414 | 0.01 | -0.9894 | 0.00577 |
| HCC1500 | AZD2014 | 0.001 | -0.9890 | -0.01822 |
| HCC1500 | Alvocidib | 1.0 | -0.9885 | 0.06446 |
| MDA-MB-361 | LY3023414 | 10.0 | -0.9848 | 0.78133 |
| HCC1500 | RO-3306 | 10.0 | -0.9842 | -0.07067 |
| HCC1500 | LY3023414 | 0.0316227766017 | -0.9830 | -0.02338 |
| HCC1500 | AZD2014 | 0.001 | -0.9813 | -0.03954 |
| HCC1500 | Senexin B | 10.0 | -0.9794 | -0.09481 |
| HCC1500 | THZ1 | 0.1 | -0.9765 | -0.09972 |
| MDA-MB-361 | LY3023414 | 10.0 | -0.9736 | 0.63357 |
| HCC1500 | LY3023414 | 0.00316227766017 | -0.9733 | 0.02000 |
| HCC1500 | LY3023414 | 0.001 | -0.9729 | -0.07680 |
| HCC1500 | Senexin B | 10.0 | -0.9724 | 0.04212 |
| HCC1500 | LY3023414 | 0.01 | -0.9698 | -0.14721 |
| HCC1500 | THZ531 | 0.316227766017 | -0.9692 | -0.03468 |
| HCC1500 | LY3023414 | 0.00316227766017 | -0.9652 | -0.09278 |